These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12805007)

  • 1. [A new, rapid and robust genotyping method for CYP2C9 and MDR1].
    Verstuyft C; Morin S; Yang J; Loriot MA; Barbu V; Kerb R; Brinkmann U; Beaune P; Jaillon P; Becquemont L
    Ann Biol Clin (Paris); 2003; 61(3):305-9. PubMed ID: 12805007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of cytochrom P450 CYP2C9 polymorphism on the pharmacokinetics of tolbutamide metabolism using oligonucleotide genotyping microarray].
    Li J; Wen SY; Wang R; Chen K; Fang Y; Pei F; Wang SQ
    Yao Xue Xue Bao; 2005 Aug; 40(8):695-9. PubMed ID: 16268502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triallelic single nucleotide polymorphisms and genotyping error in genetic epidemiology studies: MDR1 (ABCB1) G2677/T/A as an example.
    Hüebner C; Petermann I; Browning BL; Shelling AN; Ferguson LR
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1185-92. PubMed ID: 17548683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay.
    Song P; Li S; Meibohm B; Gaber AO; Honaker MR; Kotb M; Yates CR
    AAPS PharmSci; 2002; 4(4):E29. PubMed ID: 12646001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the nt230[del4] MDR1 mutation in dogs by a fluorogenic 5' nuclease TaqMan allelic discrimination method.
    Klintzsch S; Meerkamp K; Döring B; Geyer J
    Vet J; 2010 Sep; 185(3):272-7. PubMed ID: 19733104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population.
    Gümüş-Akay G; Rüstemoğlu A; Karadağ A; Sunguroğlu A
    Genet Mol Res; 2008 Oct; 7(4):1193-9. PubMed ID: 19048498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
    Illmer T; Schuler US; Thiede C; Schwarz UI; Kim RB; Gotthard S; Freund D; Schäkel U; Ehninger G; Schaich M
    Cancer Res; 2002 Sep; 62(17):4955-62. PubMed ID: 12208746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 allele.
    Womack EP; Reynolds KK; Valdes R; Linder MW
    Ther Drug Monit; 2007 Oct; 29(5):607-11. PubMed ID: 17898651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the C282Y and H63D polymorphisms associated with hereditary hemochromatosis using the ABI 7500 fast real time PCR platform.
    Tafe LJ; Belloni DR; Tsongalis GJ
    Diagn Mol Pathol; 2007 Jun; 16(2):112-5. PubMed ID: 17525682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of CYP2C9 genetics and oral contraceptives on cytochrome P450 2C9 phenotype.
    Sandberg M; Johansson I; Christensen M; Rane A; Eliasson E
    Drug Metab Dispos; 2004 May; 32(5):484-9. PubMed ID: 15100169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of DHPLC usefulness in the genotyping of GSTP1 exon 5 SNP: comparison to the PCR-RFLP method.
    Abbas A; Lepelley M; Lechevrel M; Sichel F
    J Biochem Biophys Methods; 2004 May; 59(2):121-6. PubMed ID: 15163523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory.
    Aquilante CL; Lobmeyer MT; Langaee TY; Johnson JA
    Pharmacotherapy; 2004 Jun; 24(6):720-6. PubMed ID: 15222661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology.
    Johnson VJ; Yucesoy B; Luster MI
    Cytokine; 2004 Sep; 27(6):135-41. PubMed ID: 15304242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR Green.
    Hiratsuka M; Agatsuma Y; Mizugaki M
    Mol Genet Metab; 1999 Nov; 68(3):357-62. PubMed ID: 10562462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-temperature LATE-PCR endpoint genotyping.
    Sanchez JA; Abramowitz JD; Salk JJ; Reis AH; Rice JE; Pierce KE; Wangh LJ
    BMC Biotechnol; 2006 Dec; 6():44. PubMed ID: 17144924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicolor real-time polymerase chain reaction genotyping of six human platelet antigens using displacing probes.
    Ruan L; Pei B; Li Q
    Transfusion; 2007 Sep; 47(9):1637-42. PubMed ID: 17725728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCR amplification on magnetic nanoparticles: application for high-throughput single nucleotide polymorphism genotyping.
    Liu H; Li S; Wang Z; Hou P; He Q; He N
    Biotechnol J; 2007 Apr; 2(4):508-11. PubMed ID: 17285677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a rapid and reliable method for cytochrome P450 2C8 genotyping.
    Weise A; Grundler S; Zaumsegel D; Klotzek M; Gröndahl B; Forst T; Pfützner A
    Clin Lab; 2004; 50(3-4):141-8. PubMed ID: 15074466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.